COMPREHENSIVE INVESTIGATION OF ADVERSE EVENT (AE)-RELATED COSTS IN PATIENTS WITH METASTATIC BREAST CANCER (MBC) TREATED WITH FIRST- AND SECOND-LINE CHEMOTHERAPIES

被引：0
|
作者：
Hurvitz, S. A. [1 ]
Guerin, A. [2 ]
Brammer, M. [3 ]
Guardino, E. [3 ]
Zhou, Z. Y. [4 ]
Kaminsky, M. S. [4 ]
Wu, E. Q. [4 ]
Lalla, D. [3 ]
机构：
[1] Univ Calif Los Angeles, Santa Monica, CA USA
[2] Anal Grp Ltee, Montreal, PQ, Canada
[3] Genentech Inc, San Francisco, CA 94080 USA
[4] Anal Grp Inc, Boston, MA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1244
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A418 / A418
页数：1
相关论文
共 50 条
  • [1] Comprehensive investigation of adverse event (AE)-related costs in patients with metastatic breast cancer (MBC) treated with first- and second-line chemotherapies
    Hurvitz, Sara A.
    Guerin, Annie
    Brammer, Melissa G.
    Guardino, Ellie
    Zhou, Zheng-Yi
    Kaminsky, Michael S.
    Wu, Eric Q.
    Lalla, Deepa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [2] Efficacy and safety of oral vinorelbine (NVBO) in first- or second-line metastatic breast cancer (MBC)
    Blancas, I.
    Morales, S.
    Diaz, N.
    Barnadas, A.
    Gonzalvez, M. L.
    del Barco, S.
    Lopez de Ceballos, M. H.
    Perez, F. J.
    Llombart-Cussac, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Factors associated with first- and second-line attrition among metastatic breast cancer patients
    Blondeaux, Eva
    Boni, Luca
    Chila, Giovanna
    Dri, Arianna
    Caputo, Roberta
    Poggio, Francesca
    Fabi, Alessandra
    Arpino, Grazia
    Pravisano, Federico
    Geuna, Elena
    Ruelle, Tommaso
    Giannubilo, Irene
    de Laurentiis, Michelino
    Puglisi, Fabio
    Bighin, Claudia
    Lambertini, Matteo
    Montemurro, Filippo
    Del Mastro, Lucia
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [4] Efficacy and safety of weekly oral vinorelbine (NVBO) as single agent in first- or second-line metastatic breast cancer (MBC)
    Morales, Serafin
    Blancas, Isabel
    Luisa Gonzalvez, Maria
    Barnadas, Agust
    Diaz, Nieves
    Servitja, Sonia
    del Barco, Sonia
    Margeli, Mireia
    Garcia Carbonero, Iciar
    Alvarez, Ruth
    Helena Lopez de Ceballos, Maria
    Javier Perez, Francisco
    Llombart Cussac, Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [5] First- and second-line therapy of metastatic colorectal cancer
    Terstriep, Shelby
    Grothey, Axel
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (06) : 921 - 930
  • [6] Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
    Bennett, L.
    Zhao, Z.
    Barber, B.
    Zhou, X.
    Peeters, M.
    Zhang, J.
    Xu, F.
    Wiezorek, J.
    Douillard, J-Y
    [J]. BRITISH JOURNAL OF CANCER, 2011, 105 (10) : 1495 - 1502
  • [7] Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
    Bennett, L.
    Zhao, Z.
    Barber, B.
    Zhou, X.
    Peeters, M.
    Zhang, J.
    Xu, F.
    Wiezorek, J. S.
    Douillard, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [8] Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment
    L Bennett
    Z Zhao
    B Barber
    X Zhou
    M Peeters
    J Zhang
    F Xu
    J Wiezorek
    J-Y Douillard
    [J]. British Journal of Cancer, 2011, 105 : 1495 - 1502
  • [9] Metastatic colorectal cancer:: First- and second-line treatment in 2005
    Rougier, P
    Lepère, C
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (06) : S15 - S20
  • [10] Gemcitabine plus cisplatin combination as second-line treatment in patients with metastatic breast cancer (MBC).
    Ajarim, D
    Ezzat, A
    Bazarbashi, S
    Rahal, M
    El Foudeh, M
    Pai, C
    Raja, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 70S - 70S
12345